Anti-AIDS agents 66: Syntheses and anti-HIV activity of phenolic and aza 3′,4′-di-O-(-)-camphanoyl-(+)-cis-khellactone (DCK) derivatives

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 21, 2007, Pages 6852-6858

  Suzuki, Madoka ^a   Yu, Donglei ^a   Morris Natschke, Susan L ^a   Smith, Philip C ^a   Lee, Kuo Hsiung ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

aza DCK; DCK; HIV; Khellactone

Indexed keywords

4 HYDROXY 3 METHYL 3',4' DI O CAMPHANOYL KHELLACTONE; 4 HYDROXY 3',4' DI O CAMPHANOYL KHELLACTONE; 4 HYDROXY 5 METHYL 3',4' DI O CAMPHANOYL KHELLACTONE; 4 METHYL 1' AZA 3',4' DI O CAMPHANOYL KHELLACTONE; 4 METHYL 3',4' DI O CAMPHANOYL KHELLACTONE; 6 (TERT BUTYLDIMETHYLSILANYLOXY) 4 METHYL 3',4' DI O CAMPHANOYL KHELLACTONE; 6 HYDROXY 4 METHYL 3',4' DI O CAMPHANOYL KHELLACTONE; KHELLACTONE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPOPHILICITY; MALE; NONHUMAN; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CAMPHOR; HIV-1; HUMANS; LACTONES; PHENOLS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34548532306     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.12.013     Document Type: Article

References (17)

1. Huang L., Yuan X., Yu D., Lee K.H., and Chen C.H. Virology 332 (2005) 623-628
2. Xie L., Takeuchi Y., Cosentino L.M., and Lee K.H. J. Med. Chem. 42 (1999) 2662-2672
3. Yu D., Suzuki M., Xie L., Morris-Natschke S.L., and Lee K.H. Med. Res. Rev. 23 (2003) 322-345
4. Xie L., Yu D., Wild C., Allaway G., Turpin J., Smith P.C., and Lee K.H. J. Med. Chem. 47 (2004) 756-760
5. Suzuki M., Li Y., Smith P.C., Swenberg J.A., Martin D.E., Morris-Natschke S.L., and Lee K.H. Drug Metab. Dispos. 33 (2005) 1588-1592
6. Huang L., Kashiwada Y., Cosentino L.M., Fan S., Chen C.H., McPhail A.T., Fujioka T., Mihashi K., and Lee K.H. J. Med. Chem. 37 (1994) 3947-3955
7. Roberts S.A. Curr. Opin. Drug Discov. Devel. 6 (2003) 66-80
8. Thompson T.N. Curr. Drug Metab. 1 (2000) 215-241
9. Munro H.D., Musgrave O.C., and Templeton R. J. Chem. Soc. (C) (1971) 95-98
10. Bandaranayake W.M., Crombie L., and Whiting D.A. J. Chem. Soc. (C) (1971) 811-816
11. Barton D.H.R., Donnelly D.M.X., Finet J.-P., and Guiry P.J. J. Chem. Soc., Perkin. Trans. 1 (1992) 1365-1375
12. Jolidon S., and Hansen H.J. Helv. Chim. Acta 60 (1977) 978-1032
13. Hamann L.G., Higuchi R.I., Zhi L., Edwards J.P., Wang X.N., Marschke K.B., Kong J.W., Farmer L.J., and Jones T.K. J. Med. Chem. 41 (1998) 623-639
14. Obach R.S., Baxter J.G., Liston T.E., Silber B.M., Jones B.C., MacIntyre F., Rance D.J., and Wastall P. J. Pharmacol. Exp. Ther. 283 (1997) 46-58
15. Naritomi Y., Terashita S., Kimura S., Suzuki A., Kagayama A., and Sugiyama Y. Drug Metab. Dispos. 29 (2001) 1316-1324
16. Mahmood I. Drug Metabol. Drug Interact. 19 (2002) 49-64
17. Obach R.S. Drug Metab. Dispos. 27 (1999) 1350-1359